NCT00469573View on ClinicalTrials.gov

Safety and Efficacy of Optive in Contact Lens Wearers With Dry Eyes

PHASE4CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions

Dry Eye

Interventions

DRUG

1. Optive

Optive 15ml- (in the eye) Instill one drop twice daily in each eye

Trial Locations (1)

11793

South Shore Eye Care, Wantagh

Sponsors

Lead Sponsor

Innovative Medical

All Listed Sponsors

lead

Innovative Medical

INDUSTRY

NCT00469573 - Safety and Efficacy of Optive in Contact Lens Wearers With Dry Eyes | Biotech Hunter | Biotech Hunter